Tag: GLP-1
GLP-1 Weight-Loss Drugs Reduce Breast Cancer Risk by 17% in Largest Study to Date
New research from ASCO 2026 shows GLP-1 weight-loss medications reduce breast cancer risk by 17% and cancer mortality by 24%…
Weight Loss Expert Raises Safety Concerns Over Unregulated GLP-1 ‘Microdoses’
Weight-loss specialist warns about unregulated GLP-1 microdosing trend lacking clinical trial evidence. Long-term safety effects remain unknown for reduced-dose formulations.
Scientists Discover Why Ozempic and Wegovy Weight Loss Plateaus After Initial Success
NIH scientists have discovered why GLP-1 weight-loss medications like Ozempic and Wegovy eventually plateau, with 47% of patients experiencing reduced…
GLP-1 Drugs Like Ozempic Cut Heart Attack Risk by 20% in Major Review
Major international review finds GLP-1 drugs like Ozempic reduce heart attack risk by 20% and stroke risk by 18%. The…
Submit Your Paper to GMJ
No APC until January 2027.